As of 2025-10-22, the EV/EBITDA ratio of Cytosorbents Corp (CTSO) is -3.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CTSO's latest enterprise value is 51.98 mil USD. CTSO's TTM EBITDA according to its financial statements is -14.07 mil USD. Dividing these 2 quantities gives us the above CTSO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 19.4x - 21.9x | 21.0x |
| Forward P/E multiples | 21.6x - 23.8x | 22.8x |
| Fair Price | (4.84) - (4.91) | (4.92) |
| Upside | -684.1% - -692.7% | -694.1% |
| Date | EV/EBITDA |